Medtronic 2016 Annual Report Download - page 8

Table of Contents
5
includes pain neurostimulation systems with SureScan MRI Technology, including the RestoreSensor (rechargeable) SureScan
MRI, with its proprietary AdaptiveStim technology.
Implantable Drug Infusion Systems Our SynchroMed II Implantable Infusion System delivers small quantities of drug directly
into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and severe spasticity
associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.
Deep Brain Stimulation (DBS) Systems DBS is currently approved in many countries around the world for the treatment of the
disabling symptoms of essential tremor, Parkinson's disease, refractory epilepsy (outside the U.S.), severe, treatment-resistant
obsessive-compulsive disorder (approved under a Humanitarian Device Exemption (HDE) in the U.S.), and chronic, intractable
primary dystonia (approved under a HDE in the U.S.). Our family of Activa Neurostimulators for DBS includes Activa SC (single-
channel primary cell battery), Activa PC (dual channel primary cell battery), and Activa RC (dual channel rechargeable battery).
Gastroenterology & Urology (Gastro/Uro) Systems Our Sacral neuromodulation uses InterStim, a neurostimulator, to help control
the symptoms of overactive bladder, (non-obstructive) urinary retention, and chronic fecal incontinence. Currently, Enterra Therapy
is the only gastric electrical stimulation therapy approved in the U.S. (under a HDE), Europe, and Canada for use in the treatment
of intractable nausea and vomiting associated with gastroparesis. The system, which contains a small neurostimulator and two
leads, stimulates the smooth muscles of the lower stomach.
Surgical Technologies
Our Surgical Technologies division develops, manufactures, and markets products and therapies to treat diseases and conditions
of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the division develops, manufactures, and markets
image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus,
and orthopedic surgeries. Our Advanced Energy business includes products in the emerging field of advanced energy surgical
incision technology, as well as the haemostatic sealing of soft tissue and bone.
The following are the principal products offered by our Surgical Technologies division:
Neurosurgery Our portfolio of products include both platform technologies and implant therapies. The StealthStation Navigation
System and O-arm Imaging System are both platforms used in cranial, spinal, sinus, and orthopedic procedures. The Midas Rex
Surgical Drills are used in cranial, spinal, and orthopedic procedures. Visualase MRI-Guided Laser Ablation is used in neurosurgery
procedures, and our CSF Management Portfolio is used in treating hydrocephalus and other conditions impacting the intracranial
pressure.
ENT The following products treat ENT diseases and conditions: Straightshot M5 Microdebrider Handpiece, the IPC system,
NIM Nerve Monitoring Systems, Fusion ENT Navigation System, as well as products for hearing restoration and Snoring and
Obstructive Sleep Apnea.
Advanced Energy Our PEAK Surgery System is a tissue dissection system that consists of the PEAK PlasmaBlade and PULSAR
Generator and is cleared for use in a variety of settings, including plastic reconstructive surgery, general surgery, and certain
conditions of ENT. Our Aquamantys System uses patented transcollation technology to provide haemostatic sealing of soft tissue
and bone and is cleared for use in a variety of surgical procedures, including orthopedic surgery, spine, solid organ resection and
thoracic procedures.
Neurovascular
Our Neurovascular division, develops, manufactures, and markets products and therapies to treat diseases of the vasculature in
and around the brain. Our products include coils, neurovascular stents, and flow diversion products, as well as access and delivery
products to support procedures.
The following are the principal products offered by our Neurovascular division:
The Pipeline and Pipeline Flex Embolization Devices, endovascular treatments for large or giant wide-necked brain aneurysms;
the Solitaire FR revascularization device for treatment of acute ischemic stroke; and the Apollo Onyx delivery micro catheter, the
first detachable tip micro-catheter available in the U.S.
DIABETES GROUP
Our Diabetes group consists of three divisions (Intensive Insulin Management, Non-Intensive Diabetes Therapies, and Diabetes
Service & Solutions) that develop, manufacture, and market advanced, integrated diabetes management solutions that include
insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management software.